Advagen Pharma Recalls Metoprolol Tartrate Tablets Due to Foreign Material
Advagen Pharma Limited is recalling 3,684 bottles of Metoprolol Tartrate 50 mg tablets because they may contain foreign tablets or capsules.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to the presence of foreign tablets or capsules, a hazard that may cause temporary or medically reversible adverse health consequences. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Advagen Pharma Limited is recalling 3,684 bottles of Metoprolol Tartrate Tablets, USP, 50 mg. The recall was initiated because the product may contain foreign tablets or capsules. The affected product is distributed nationwide in the United States.
The specific product involved is identified by Batch number 2611C065A1 with an expiration date of 05/2028. The product is a prescription-only medication distributed by Advagen Pharma Ltd. in East Windsor, NJ.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for further instructions. The source text does not report any illnesses, injuries, or deaths associated with this recall.
The recalled product
- Product
- METOPROLOL TARTRATE (METOPROLOL TARTRATE)
- Brand
- METOPROLOL TARTRATE
- Manufacturer
- Advagen Pharma Limited
- Category
- Drug — Prescription Drug
- Hazard
- Affected units
- 3,684
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch#: 2611C065A1: Expiry: 05/2028
UPCs (13)
- 0372888212005
- 0372888209050
- 0372888208008
- 0372888209012
- 0372888211053
- 0372888212012
- 0372888212050
- 0372888211015
- 0372888210056
- 0372888208015
- 0372888210001
- 0372888210018
- 0372888208053
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · METOPROLOL TARTRATE
- HighMetoprolol Tartrate Tablets Recalled Nationwide for Metal Contamination
FDA (Drugs) · 2024-06-05
- HighMetoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets
FDA (Drugs) · 2022-01-19
- HighMetoprolol Tartrate Tablets Recalled for Metal Wire Contamination
FDA (Drugs) · 2021-09-29
Same hazard · foreign object
See all →- ModerateCyanocobalamin Injection Recalled for Potential Glass Particle Contamination
FDA (Drugs) · 2026-11-11
- SevereStryker Precision Pointer Electromagnetic Recalled for Potential Fracture During Use
FDA (Devices) · 2026-11-04
- SevereAtorvastatin Calcium Tablets Recalled for Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-11-04
- SeverePar Health Recalls Argatroban Injection Vials Due to Particulate Matter
FDA (Drugs) · 2026-10-28
- ModerateGearharts Fine Chocolates Recalled Due to Broken Glass Foreign Object
FDA (Food) · 2026-10-28
Similar recalls
- ModerateTeva Recalls Metoclopramide Tablets Due to Foreign Object Presence
FDA (Drugs) · 2026-10-21
- HighMetoprolol Tartrate Tablets Recalled for Foreign Metal in Tablets
FDA (Drugs) · 2022-01-19
- SevereMetoclopramide Tablets Recalled for Presence of Foreign Tablets
FDA (Drugs) · 2025-07-02
- ModerateMetoclopramide Tablets Recalled Due to Presence of Foreign Tablets or Capsules
FDA (Drugs) · 2026-10-21
- SevereTeva Recalls Trazodone Hydrochloride Tablets Due to Foreign Material
FDA (Drugs) · 2026-09-09
- HighMetoprolol Tartrate Tablets Recalled Nationwide for Metal Contamination
FDA (Drugs) · 2024-06-05